https://www.businesswire.com/news/home/20240408718700/en/Data-from-Newron’s-study-014015-and-an-evenamide-clinical-development-outlook-presented-at-the-2024-Annual-Congress-of-the-Schizophrenia-International-Research-Society-SIRS